TGFB1 and familial pancreatic carcinoma: Furthermore, our results also indicated that ITGA2 silencing enhanced the anti-pancreatic cancer cell proliferation effect of TGF-β treatment, and the combined treatment might represent a novel therapeutic strategy for pancreatic cancer.